Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Frank E Thomas

Director at Larimar Therapeutics, Inc. (LRMR)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-32.9%
vs. S&P 500-43.7%
Beat the market0%
Paper profit on buys−$12K
Total bought / sold$25K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Mar 2SEC LRMRLarimar Therapeutics, Inc. Buy 5,0007,000 held (+250%) $5.00 $25K -46.6%
  • Buy

    Director Frank E Thomas bought $25K of LRMR at $5.00 — first open-market purchase in our records; raises the stake by 250%.